SCHEDULE 13G/A 0001213900-21-045460 0001646799 XXXXXXXX LIVE 5 Common Stock, $0.0001 par value per share 12/31/2024 0001157075 PharmaCyte Biotech, Inc. 717512X203 3960 Howard Hughes Parkway Suite 500 Las Vegas NV 89169 Rule 13d-1(c) Mitchell P. Kopin X1 0.00 714844.00 0.00 714844.00 714844.00 N 9.99 HC IN Daniel B. Asher X1 82727.00 622936.00 82727.00 622936.00 705663.00 N 9.99 HC IN Intracoastal Capital LLC DE 0.00 714844.00 0.00 714844.00 714844.00 N 9.99 OO PharmaCyte Biotech, Inc. 3960 Howard Hughes Parkway, Suite 500, Las Vegas, NV 89169 This Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual ("Mr. Kopin"), (ii) Daniel B. Asher, an individual ("Mr. Asher") and (iii) Intracoastal Capital LLC, a Delaware limited liability company ("Intracoastal" and together with Mr. Kopin and Mr. Asher, collectively the "Reporting Persons"). The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483. The principal business office of Mr. Asher is 111 W. Jackson Boulevard, Suite 2000, Chicago, Illinois 60604 Mr. Kopin is a citizen of the United States of America. Mr. Asher is a citizen of the United States of America. Intracoastal is a Delaware limited liability company. Y As of the close of business on December 31, 2024, each of Intracoastal and Mr. Kopin may have been deemed to have beneficial ownership of 714,844 shares of Common Stock, which consisted of (i) 527,376 shares of Common Stock held by Intracoastal and (ii) 187,468 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal ("Intracoastal Warrant 1"), and all such shares of Common Stock represented beneficial ownership of approximately 9.99% of the Common Stock, based on (1) 6,968,134 shares of Common Stock outstanding as of December 9, 2024, as reported by the Issuer, plus (2) 187,468 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1. The foregoing excludes (I) 312,532 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1 because Intracoastal Warrant 1 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 1 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Common Stock, (II) 129,147 shares of Common Stock issuable upon exercise of a second warrant held by Intracoastal ("Intracoastal Warrant 2") because Intracoastal Warrant 2 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 2 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock and (III) 2,312,500 shares of Common Stock issuable upon exercise of a third warrant held by Intracoastal ("Intracoastal Warrant 3") because Intracoastal Warrant 3 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 3 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock. Without such blocker provisions, each of Intracoastal and Mr. Kopin may have been deemed to have beneficial ownership of 3,469,023 shares of Common Stock. As of the close of business on December 31, 2024, Mr. Asher may have been deemed to have beneficial ownership of 705,663 shares of Common Stock, which consisted of (i) 527,376 shares of Common Stock held by Intracoastal, (ii) 82,727 shares of Common Stock held by Mr. Asher and (iii) 95,560 shares of Common Stock issuable upon exercise Intracoastal Warrant 1, and all such shares of Common Stock represented beneficial ownership of approximately 9.99% of the Common Stock, based on (1) 6,968,134 shares of Common Stock outstanding as of December 9, 2024, as reported by the Issuer, plus (2) 95,560 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1. The foregoing excludes (I) 404,440 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1 because Intracoastal Warrant 1 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 1 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Common Stock, (II) 608,553 shares of Common Stock issuable upon exercise of a warrant held by Mr. Asher (the "Asher Warrant") because the Asher Warrant contains a blocker provision under which the holder thereof does not have the right to exercise the Asher Warrant to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock, (III) 129,147 shares of Common Stock issuable upon exercise of Intracoastal Warrant 2 because Intracoastal Warrant 2 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 2 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock and (IV) 2,312,500 shares of Common Stock issuable upon exercise of Intracoastal Warrant 3 because Intracoastal Warrant 3 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 3 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock. Without such blocker provisions, Mr. Asher may have been deemed to have beneficial ownership of 4,160,303 shares of Common Stock. 9.99 0 shares of Common Stock with respect to Mr. Kopin and Intracoastal. 82,727 shares of Common Stock with respect to Mr. Asher. 714,844 shares of Common Stock with respect to Mr. Kopin and Intracoastal. 705,663 shares of Common Stock with respect to Mr. Asher. 0 shares of Common Stock with respect to Mr. Kopin and Intracoastal. 82,727 shares of Common Stock with respect to Mr. Asher. 714,844 shares of Common Stock with respect to Mr. Kopin and Intracoastal. 705,663 shares of Common Stock with respect to Mr. Asher. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Mitchell P. Kopin /s/ Mitchell P. Kopin 01/15/2025 Daniel B. Asher /s/ Daniel B. Asher 01/15/2025 Intracoastal Capital LLC /s/ Mitchell P. Kopin 01/15/2025